SG11201900596XA - Cannabis composition - Google Patents
Cannabis compositionInfo
- Publication number
- SG11201900596XA SG11201900596XA SG11201900596XA SG11201900596XA SG11201900596XA SG 11201900596X A SG11201900596X A SG 11201900596XA SG 11201900596X A SG11201900596X A SG 11201900596XA SG 11201900596X A SG11201900596X A SG 11201900596XA SG 11201900596X A SG11201900596X A SG 11201900596XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- bay
- western australia
- perth
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662370303P | 2016-08-03 | 2016-08-03 | |
PCT/AU2017/050815 WO2018023164A1 (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201900596XA true SG11201900596XA (en) | 2019-02-27 |
Family
ID=61072439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201900596XA SG11201900596XA (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Country Status (11)
Country | Link |
---|---|
US (2) | US20190307719A1 (es) |
EP (1) | EP3493799A4 (es) |
JP (1) | JP2019523282A (es) |
KR (1) | KR20190033590A (es) |
CN (1) | CN109789124A (es) |
AU (5) | AU2017307644B2 (es) |
CA (1) | CA3031811A1 (es) |
CL (1) | CL2019000268A1 (es) |
PE (1) | PE20200676A1 (es) |
SG (1) | SG11201900596XA (es) |
WO (1) | WO2018023164A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2019001285A (es) | 2016-08-03 | 2019-06-13 | Zelda Therapeutics Operations Pty Ltd | Composicion de cannabis. |
AU2017307644B2 (en) | 2016-08-03 | 2019-06-20 | Zelira Therapeutics Operations Pty Ltd | Cannabis composition |
JP2019526541A (ja) | 2016-08-03 | 2019-09-19 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US11484510B2 (en) * | 2017-08-28 | 2022-11-01 | Apirx Pharmaceutical Usa, Llc | Method to treat vitiligo |
US11202771B2 (en) | 2018-01-31 | 2021-12-21 | Treehouse Biotech, Inc. | Hemp powder |
EP3793542A4 (en) * | 2018-05-14 | 2022-03-30 | Buzzelet Development And Technologies Ltd | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES |
US10736869B2 (en) * | 2018-07-16 | 2020-08-11 | ECS Health Sciences, Inc. | Compositions and methods related to cannabinoids, terpenoids and essential oils |
US11013715B2 (en) * | 2018-07-19 | 2021-05-25 | Vertosa, Inc. | Nanoemulsion hydrophobic substances |
IL261774B (en) * | 2018-09-13 | 2020-04-30 | Unv Medicine Ltd | Compositions for treating dermatological conditions |
CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
WO2020086291A1 (en) * | 2018-10-22 | 2020-04-30 | Jones Lisa Marie | Topical compositions incorporating cannabis |
WO2020123383A1 (en) * | 2018-12-10 | 2020-06-18 | Natural Extraction Systems, LLC | Compositions with novel cannabinoid and terpene profiles |
WO2020129044A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis lines and extracts for skin rejuvenation and skin protection |
WO2020129043A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis sativa lines and extracts with anti-cancer properties |
WO2020129045A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis lines and extracts for treating skin disorders |
CN114269333A (zh) * | 2018-12-25 | 2022-04-01 | Epm (Ip)公司 | 用于美容或可食用组合物的大麻二酚酸酯 |
EP3906025A4 (en) * | 2019-01-04 | 2022-09-21 | Columbia Care LLC | CANNABINOID TOPICAL FORMULATIONS |
US11246310B2 (en) * | 2019-02-08 | 2022-02-15 | Global Biolife Inc. | Insect repelling composition |
US20200345686A1 (en) * | 2019-04-30 | 2020-11-05 | Vcp Ip Holdings, Llc, Limited Liability Company Delaware | Compositions and methods for treating skin and neuropathic conditions and disorders |
US10717056B1 (en) | 2019-09-09 | 2020-07-21 | Michael Cem Gokay | Method and apparatus for purification of cannabinoid extracts |
US20210093539A1 (en) * | 2019-09-30 | 2021-04-01 | Concept Matrix Solutions | Topical cosmetic |
US20210113490A1 (en) * | 2019-10-21 | 2021-04-22 | Avicanna Inc. | Topical cannabinoid compositions for clear skin |
US10941131B1 (en) * | 2019-10-28 | 2021-03-09 | Pure Tonic Concentrates, LLC | Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures |
WO2021127559A1 (en) * | 2019-12-19 | 2021-06-24 | Natural Extraction Systems, LLC | Compositions comprising cannabinoid anions and anti-nucleating agents |
US11590187B2 (en) * | 2020-01-14 | 2023-02-28 | Shaman Naturals, Llc | Antimicrobial compositions |
US20210346276A1 (en) * | 2020-05-05 | 2021-11-11 | Gm Pharmaceuticals, Inc. | Skincare compositions containing cannabidiol |
US20210369802A1 (en) * | 2020-06-01 | 2021-12-02 | James Chuang | Cannabis plant formulations and methods of delivery |
US20220054446A1 (en) * | 2020-08-18 | 2022-02-24 | Yvette Rose Webb | Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils |
WO2023152748A1 (en) * | 2022-02-13 | 2023-08-17 | Reagenics Research Ltd. | Plant-based skin preparations and use thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
JP2004002237A (ja) * | 2002-05-31 | 2004-01-08 | Noriko Yagi | 老化防止ハーブ |
EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
EP2444081B1 (en) * | 2010-10-19 | 2015-04-08 | Parenteral, A.S. | A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol |
US20120264818A1 (en) * | 2011-04-15 | 2012-10-18 | Jon Newland | Topical Compositions with Cannabis Extracts |
US20130184354A1 (en) * | 2012-01-13 | 2013-07-18 | Donna K. Jackson | Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management |
US20130274321A1 (en) * | 2012-03-30 | 2013-10-17 | Jon Newland | Topical Compositions with Cannabis Extracts |
SI2844243T1 (sl) * | 2012-05-03 | 2020-02-28 | Echo Pharmaceuticals B.V. | Metoda za pripravo izolata iz rastline konoplje, ki obsega delta-9-tetrahidrokanabinol |
WO2014100231A1 (en) * | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
EP2968259B1 (en) * | 2013-03-14 | 2022-09-14 | SC Laboratories Inc. | Bioactive concentrates and uses thereof |
MX2015013202A (es) * | 2013-03-15 | 2016-04-07 | Biotech Inst Llc | Cultivo, produccion, procesamiento y uso de cannabis de especialidad. |
CN105764504A (zh) * | 2013-09-26 | 2016-07-13 | 罗纳德·D·塞库拉 | 引入大麻种衍生的植物药品的局部治疗 |
SI3062606T1 (sl) * | 2013-10-29 | 2019-09-30 | Biotech Institute, Llc | Gojenje, priprava, predelava in uporaba posebnega kanabisa |
JP6377423B2 (ja) * | 2014-06-17 | 2018-08-22 | ロート製薬株式会社 | 外用組成物 |
WO2015200049A1 (en) * | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
EP3217995A1 (en) * | 2014-08-25 | 2017-09-20 | Janing Holding ApS | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
CA2859930A1 (en) * | 2014-09-22 | 2016-03-22 | Antony Paul Hornby | A cannabis topical from heat treated cocount oil |
EP3209312A1 (en) * | 2014-10-21 | 2017-08-30 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
US20160309774A1 (en) * | 2015-04-27 | 2016-10-27 | Michael D. Wand | Terpene carrier |
EP3380096A4 (en) * | 2015-11-24 | 2019-10-23 | Constance Therapeutics, Inc. | CANNABIS OIL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
AU2016367036B2 (en) * | 2015-12-09 | 2019-04-18 | Poviva Corp. | Methods for formulating orally ingestible compositions comprising lipophilic active agents |
CA3011185A1 (en) * | 2016-01-20 | 2017-07-27 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
IL307857A (en) * | 2016-03-16 | 2023-12-01 | Buzzelet Development And Technologies Ltd | Cannobinoid compounds are rich in terpenes |
IL246790A0 (en) * | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
AU2017307644B2 (en) | 2016-08-03 | 2019-06-20 | Zelira Therapeutics Operations Pty Ltd | Cannabis composition |
-
2017
- 2017-08-03 AU AU2017307644A patent/AU2017307644B2/en active Active
- 2017-08-03 US US16/322,898 patent/US20190307719A1/en not_active Abandoned
- 2017-08-03 CA CA3031811A patent/CA3031811A1/en active Pending
- 2017-08-03 CN CN201780060682.7A patent/CN109789124A/zh active Pending
- 2017-08-03 WO PCT/AU2017/050815 patent/WO2018023164A1/en active Search and Examination
- 2017-08-03 PE PE2019000308A patent/PE20200676A1/es unknown
- 2017-08-03 KR KR1020197005608A patent/KR20190033590A/ko not_active Application Discontinuation
- 2017-08-03 JP JP2019505170A patent/JP2019523282A/ja active Pending
- 2017-08-03 SG SG11201900596XA patent/SG11201900596XA/en unknown
- 2017-08-03 EP EP17836098.8A patent/EP3493799A4/en active Pending
-
2018
- 2018-07-03 AU AU2018100921A patent/AU2018100921B4/en active Active
-
2019
- 2019-01-31 CL CL2019000268A patent/CL2019000268A1/es unknown
- 2019-07-23 AU AU2019208177A patent/AU2019208177B2/en active Active
-
2021
- 2021-10-01 AU AU2021240296A patent/AU2021240296B2/en active Active
-
2022
- 2022-07-28 US US17/876,071 patent/US20220362208A1/en active Pending
-
2024
- 2024-05-24 AU AU2024203468A patent/AU2024203468A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20190033590A (ko) | 2019-03-29 |
US20220362208A1 (en) | 2022-11-17 |
AU2018100921A4 (en) | 2018-08-02 |
AU2019208177B2 (en) | 2021-07-01 |
CN109789124A (zh) | 2019-05-21 |
JP2019523282A (ja) | 2019-08-22 |
AU2017307644B2 (en) | 2019-06-20 |
EP3493799A1 (en) | 2019-06-12 |
EP3493799A4 (en) | 2020-04-01 |
WO2018023164A1 (en) | 2018-02-08 |
AU2019208177A1 (en) | 2019-08-08 |
PE20200676A1 (es) | 2020-06-11 |
AU2017307644A1 (en) | 2018-07-05 |
AU2018100921B4 (en) | 2019-02-14 |
AU2021240296B2 (en) | 2024-03-07 |
AU2021240296A1 (en) | 2021-10-28 |
AU2024203468A1 (en) | 2024-06-13 |
CL2019000268A1 (es) | 2019-10-04 |
US20190307719A1 (en) | 2019-10-10 |
CA3031811A1 (en) | 2018-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201900596XA (en) | Cannabis composition | |
SG11201900501RA (en) | Cannabis composition | |
SG11201900665VA (en) | Cannabis composition | |
SG11201804118VA (en) | Compositions comprising bacterial strains | |
SG11201906431UA (en) | Method for the treatment of thromboembolism | |
SG11201810420YA (en) | Antibodies to alpha-synuclein and uses thereof | |
SG11201903359RA (en) | Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma | |
SG11201908420WA (en) | Compositions of plinabulin and use thereof | |
SG11201907427YA (en) | Engineered transferrin receptor binding polypeptides | |
SG11201804211YA (en) | Compositions comprising bacterial strains | |
SG11201804098TA (en) | Purinones as ubiquitin-specific protease 1 inhibitors | |
SG11201804161VA (en) | Compositions comprising bacterial strains | |
SG11201906885TA (en) | Methods for the administration of certain vmat2 inhibitors | |
SG11201804368QA (en) | Storage assembly for prosthetic valve | |
SG11201909963YA (en) | Methods for treating dravet syndrome | |
SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
SG11201907435PA (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
SG11201909019SA (en) | Methods of treatment using a jak inhibitor compound | |
SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
SG11201805579SA (en) | Recombinant igg fc multimers | |
SG11201803834UA (en) | Methods for treating conditions associated with masp-2 dependent complement activation | |
SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof |